Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patents for C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
12/2007
12/12/2007EP1863776A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations
12/06/2007WO2007139002A1 Method for producing nitrogen-containing fused ring compound
12/06/2007WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound
12/05/2007EP1861385A1 Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (ryr2)
12/05/2007EP1404324B1 Prodrugs of gaba analogs, compositions and uses thereof
11/2007
11/29/2007WO2007135295A2 Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides, preparation and use thereof, and compositions containing the same
11/29/2007US20070276137 Salt formation via enantiomer of O,O-diaroyltartaric acid as resolving agent
11/29/2007CA2649685A1 Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation et utilisation connexes, et compositions contenant lesdits derives
11/27/2007US7301020 identifying macrolide analogs capable of unregulated inhibition of actin filament dynamics; kabiramide C where the 7'-hydroxyl position on the macrolide ring is modified with a methoxycourmarin (MC) or a diethylaminocoumarin (DEAC) group; use of macrolide in fluorescence microscopy of actin filaments
11/27/2007US7300924 Conjugate of rifampicin linked to one or more phosphonate groups; allows accumulation or retention inside cells; improved anti-infective activity and pharmacokinetic properties, including oral bioavailability, greater potency and half-life in vivo
11/22/2007WO2007132255A2 Racemisation of enantiomers of nefopam and analogues
11/22/2007WO2007062336A3 Salt forms
11/22/2007CA2652250A1 Racemisation of enantiomers of nefopam and analogues
11/21/2007EP1856071A1 Benzoxazocines and their therapeutic use
11/15/2007WO2007062338A3 Solid formulations
11/14/2007CN101072760A Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
11/13/2007US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007US7294622 Lactams and uses thereof
11/13/2007CA2231052C Benzoxazepine compounds, their production and use as lipid lowering agents
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007056086A3 Rifamycin analogs and uses thereof
11/08/2007CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/07/2007EP1850855A2 Compounds and uses thereof
11/01/2007US20070254866 Aminoquinolones as GSK-3 inhibitors
10/2007
10/24/2007CN101060847A Loxapine analogs and methods of use thereof
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/17/2007EP1845089A1 Novel lactams and uses thereof
10/11/2007WO2007008226A3 Palladium-catalyzed carbon-carbon bond forming reactions
10/11/2007US20070238721 Highly Selective Novel Amidation Method
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
09/2007
09/27/2007US20070225313 Epimers and isomers of tetrazole containing rapamycin analogs, methods of making and using the same
09/26/2007EP1554250B1 Novel lactams and uses thereof
09/26/2007EP1341753B1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/20/2007WO2007104933A1 Chemical compounds
09/19/2007CN101039925A Benzoxazepine derivatives as selective estrogen receptor modulators
09/19/2007CN100338043C Method for extracting a macrolide from biomatter
09/18/2007US7271154 Such as penicillin G coupled to 2'deoxyazithromycin; drug delivery
09/13/2007WO2007101347A1 Bir domain binding compounds
09/13/2007US20070213525 meridamycin derivatives used as neuroprotectants, prepared by reacting meridamycin with a dialkoxyalkane in the presence of an acid catalyst, then reacting the with the periodinane and treating with tetrapropylammonium ruthenate and N-morpholine oxide; polyketides
09/12/2007EP1831187A1 Novel molecular probes
09/12/2007CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
09/05/2007EP1828151A2 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
09/05/2007CN101029047A Isocoumarin compound with antineoplastic and antiulcer activities
08/2007
08/23/2007WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
08/22/2007EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/21/2007US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
08/14/2007US7256286 Bryostatins exhibit potent activity against a broad range of human cancer cell lines
08/09/2007US20070185081 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct
08/08/2007EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
08/08/2007EP1324992B1 Cyclized benzamide neurokinin antagonists for use in therapy
08/02/2007WO2007024745A3 Phosphorus-containing macrocycles
08/01/2007EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents
07/2007
07/19/2007WO2007064931A3 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
07/18/2007CN101001854A Highly selective novel amidation method
07/11/2007EP1805202A2 Conjugates with anti-inflammatory activity
07/11/2007EP1804804A2 Loxapine analogs and methods of use thereof
07/04/2007EP1802595A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
06/2007
06/27/2007CN1989141A Bicyclic heterocycles as HIV integrase inhibitors
06/26/2007US7235550 Polycyclic azaindole compounds
06/21/2007US20070142423 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
06/13/2007EP1794137A2 Specific kinase inhibitors
06/13/2007EP1330425B1 C-nitroso compounds and use thereof
06/12/2007US7229984 Dibenzoxazepinone derivatives and uses thereof
06/07/2007WO2007064316A1 Bicyclic heterocycles as hiv integrase inhibitors
06/07/2007US20070129348 Receptor antagonist
06/07/2007CA2631741A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
05/2007
05/31/2007WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same
05/29/2007US7223749 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
05/29/2007US7223553 Immunoassays for everolimus
05/24/2007US20070117976 Method of purifying macrolides
05/24/2007US20070117787 N-[(3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]piperidine-4-acetic acid; in combination with a statin, lowering cholesterol-level and lowering triglyceride-level
05/18/2007CA2628403A1 Rifamycin analogs and uses thereof
05/10/2007WO2007053618A1 Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
05/10/2007US20070106074 Iron catalyzed cross-coupling reactions of imidoyl derivatives
05/09/2007EP1781661A2 Vasopressin v1a antagonists
05/02/2007EP1778656A1 Benzoxazepine derivatives as selective estrogen receptor modulators
05/01/2007US7211573 Malonamide derivatives
04/2007
04/26/2007WO2007047737A1 Cb-1 modulating compounds and their use
04/26/2007WO2007024501A3 Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore
04/26/2007CA2625423A1 Cb-1 modulating compounds and their use
04/25/2007EP1776160A1 Novel serotonin receptor ligands and their uses thereof
04/25/2007EP1631296B1 2,3,4,5-tetrahydrobenzo¬f|¬1,4|oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
04/19/2007WO2006088786A3 Compounds and uses thereof
04/18/2007EP1692118B1 A process for the resolution of nefopam
04/17/2007US7205401 Separation of such enantiomers with non-chromatographic resin bed separations of three separation stages or less; efficiency; chiral purity
04/17/2007US7205334 vacuolar-type (H+)-ATPase-inhibiting macrocyclic lactams belonging to the chondropsin class useful in cancer chemotherapy
04/11/2007EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof
04/05/2007WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same
04/05/2007US20070078258 Purification process
04/04/2007CN1942456A Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
03/2007
03/28/2007CN1935787A Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/15/2007US20070060748 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
03/13/2007US7189582 Compositions and methods for detection of sirolimus
03/13/2007CA2286610C Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
03/08/2007WO2006116727A3 Compositions and methods for detection of sirolimus
03/07/2007CN1923794A Process for production of high-purity enamines
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 21